First 100 Patients Treated in Europe with the MitraClip(R) System for Percutaneous Mitral Repair
Use of the MitraClip(R) Therapy Continues to Expand in Europe MENLO PARK, Calif., May 14 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip(R...First Dutch Patients Treated With the Percutaneous MitraClip(R) System
MENLO PARK, Calif., Feb. 12 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first series of patients have been successfully treated with the MitraClip(R) system at the St. Antonius Hospital, Nieuwege...Cone-beam CT: Just as useful as MDCT before and after percutaneous vertebroplasty
Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan. Percutaneous vertebroplasty is a mini...First Patients Treated in Italy With the Percutaneous MitraClip(R) System
Use of the MitraClip System Expands in the European Union MENLO PARK, Calif., Oct. 21 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first two patients in Italy have been treated with the Mit...Correction: Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System
MENLO PARK, Calif., March 25 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today CE Mark approval for its MitraClip(R) system. The MitraClip is the first commercially available device which enables a non-surgical...Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System
MENLO PARK, Calif., March 25 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today CE Mark approval for its MitraClip(R) system. The MitraClip is the first commercially available device which enables a non-surgical...Medicare Sets Physician Payment Rate for Percutaneous Kidney Cryoablation
New Clinical CPT Code Created for Minimally Invasive Procedure to Treat Kidney Tumors IRVINE, Calif., Nov. 7 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO ), an innovative medical device company focused on the development of minimally invasive technologies...First Swiss Patients Treated with the Percutaneous MitraClip(R) System
Use of the MitraClip(R) System Continues to Expand in the European Union MENLO PARK, Calif., March 10 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first series of patients have been successfully ...First European Patients Treated With the Percutaneous MitraClip(R) System
European Physicians Show Strong Interest in MitraClip System MENLO PARK, Calif., Sept. 23 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first two patients have been treated with its MitraClip...Myocor Receives Approval for Percutaneous Trial
MAPLE GROVE, Minn., Dec. 5 /PRNewswire/ -- Myocor, Inc. announced that the U.S. Food and Drug Administration has granted conditional approval of the Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) feasibility study. The single-arm feasibility study will evaluate the safety a...R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
...ntration in the blood was measured, the level was below the quantification limit as in the case of the single-dose study. As described above, percutaneous absorption of the drug was not high even after continuous application in the morning and at night for 5 days, suggesting hardly any safety problem. ...Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
...sed on the results of the company's VerifyNow P2Y12 Test, reduces major cardiovascular adverse events (e.g., heart attack, stent thrombosis) following percutaneous coronary intervention (PCI). Currently the trial is being conducted at more than 70 sites in the U.S. and Canada, with a total enrollment goal of app...Portex® ULTRAperc® Percutaneous DilationTracheostomy Kit without Tube
Description: The Portex® ULTRAperc® Percutaneous Dilation Tracheostomy Kits allow the percutaneous insertion of a tracheostomy tube using the widely accepted Seldinger technique by means of a single-stage curved dilator. Kits are available with or without the Portex® Blue Line ULTRA® tracheostom...Portex® ULTRAperc® Percutaneous DilationTracheostomy Kits with Blue Line ULTRA® Tube
Description: The Portex® ULTRAperc® Percutaneous Dilation Tracheostomy Kits allow the percutaneous insertion of a tracheostomy tube using the widely accepted Seldinger technique by means of a single-stage curved dilator. Kits are available with or without the Portex® Blue Line ULTRA® tracheostom...535080 Per-fit™ Percutaneous Tracheostomy Kit
Description: Each kit features a patented Per-fit™ flexible PVC tube with a tapered distal tip and a low-profile cuff specifically designed to reduce insertion force and more readily conform to the patients anatomy. The kit s unique obturator/dilator design is engineered to fit the tube snugly, allowing f...535090 Per-fit™ Percutaneous Tracheostomy Kit
Description: Each kit features a patented Per-fit™ flexible PVC tube with a tapered distal tip and a low-profile cuff specifically designed to reduce insertion force and more readily conform to the patients anatomy. The kit s unique obturator/dilator design is engineered to fit the tube snugly, allowing f...535070 Per-fit™ Percutaneous Tracheostomy Kit
Description: Each kit features a patented Per-fit™ flexible PVC tube with a tapered distal tip and a low-profile cuff specifically designed to reduce insertion force and more readily conform to the patients anatomy. The kit s unique obturator/dilator design is engineered to fit the tube snugly, allowing f...Replacement Per-fit™ Percutaneous Tracheostomy Tubes
Description: Per-fit™ tubes are a dual cannula system with daily replacement of the disposable inner cannula recommended. One inner cannula is provided in the procedural tray. Additional inner cannula and Per-ft™ tubes are available separately. Per-fit™ kits are available in three color-coded ...Neonatal Percutaneous Pigtail Nephrostomy Set
Description: Used for percutaneous placement of a pigtail catheter in the renal pelvis for nephrostomy drainage in neonatal and pediatric patients. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; catheter must not remain indwelling more than four (4) m...Flat-Wire Percutaneous Stone Extractors
Description: Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....Helical Percutaneous Stone Extractors
Description: Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes
Description: ACMITM MRO™-2004 and MRO™-2005 Rigid Percutaneous Nephroscopes combine small diameter convenience and large working throughput capacity with proven MRO performance. These nephroscopes provide large operating channels with small size sheaths. The MRO™-20 sheaths have rotating irrig...Findings released from 1 of the largest percutaneous coronary intervention trials ever
NEW YORK (May 23, 2008) A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudi...Freezing kidney cancer: Hot treatment should be new gold standard for destroying small tumors
...kins studies, examining the safety and efficacy of percutaneous (no incision) cryoablation, show the treatment's p...le within a year with a CT scan or MRI. The use of percutaneous cryoablation should not be limitedas it has beento.... When comparing the rate of complications between percutaneous cryoablation and surgery, Georgiades said that non...Latest advances in interventional cardiology for congenital heart disease presented
...amen ovale. As a result of his research, the FDA approved the first ASD closure device for use in children in 2001. Currently, Hijazi is evaluating percutaneous valve implantation for patients with defective pulmonary valves. In 2005, Hijazi became the first person in the United States to perform this innovati...New data shows benefits of MitraClip for patients with mitral regurgitation
...4, 2007 The vast majority of patients who had a successful result with the percutaneous MitraClip device did not need mitral valve surgery three years after their ...ollowing the procedure. Our work to reduce mitral regurgitation with a percutaneous approach continues to produce compelling results, said Ted Feldman, M.D., w...High-dose anticlotting drug cuts heart attack, death risk in half
... Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention (PCI) cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th Annual Scienti...Protein therapy may reduce infarct size in heart attack patients
...n heart attack patients. In the DELTA MI trial, the DCRI team evaluated KAI-9803 in 154 patients with anterior ST-elevation MI undergoing primary percutaneous coronary intervention with balloon angioplasty and coronary stent implantation. Patients were randomized 2:1 to receive intracoronary injections of t...Cryoablation -- A new treatment option for some kidney tumor patients
...archers report that freezing kidney tumors through percutaneous cryoablation shows promise for patients who are no...not able to have surgery because of other factors, percutaneous cryoablation may be an option. "This procedur...r only a relatively small subset of patients. percutaneous ablation uses needles to penetrate the skin and de...Potential heart benefit found in stem cells
..., or blockages in the arteries leading to the heart infarction. In the study, 17 patients with ischemic cardiomyopathy were treated with a combined percutaneous injection (both intramyocardial and intracoronary, either the heart muscle or the heart's artery) of bone marrow-derived mononuclear cells. At baseli...Stem cell mobilization therapy appears to be ineffective in repairing damage caused by heart attack
...farction (a certain pattern on an electrocardiogram indicating a heart attack), had successful reperfusion (restoration of blood flow) to the heart by percutaneous coronary intervention (procedures such as angioplasty in which a catheter-guided balloon is used to open a narrowed coronary artery) within 12 hours a...New cell transplantation technique restores insulin production in diabetics
...nique is so-called because of the layered applications of gelfoam and coil used to close the access site." Dr. Krishnamoorthy said that even though percutaneous islet cell transplantation is currently an experimental procedure, the sandwich closure is a safe method that prevents many of the complications commo...First United Kingdom Patients Treated With Percutaneous MitraClip(R) System
MENLO PARK, Calif., Nov. 26 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first three patients have been successfully treated with the MitraClip(R) system at the University of Hull, Castle Hill Hospita...Regado Biosciences Expands Medical Advisory Board
...B007). RB007 can be used to completely or partially reverse the anticoagulant effect of RB006. Regado recently completed a phase 2a study of REG1 in percutaneous coronary intervention (PCI) and will initiate a rigorous phase 2b program in 3Q09 in patients with Acute Coronary Syndrome undergoing PCI (the RADAR t...New Report Just Published: World Endoscopy Systems Market Report
...id and Flexible Endoscopes: A Comparison II-12 percutaneous Fiberscopes II-12 Fiberoptic Instruments II-13...gulation II-36 Nutritional Disorders II-37 percutaneous Endoscopic Gastrotomy II-37 percutaneous Endoscopic Gastrotomy Jejunostomy II-37 Direct...Delcath Enters Agreement to Sell 869,565 Units
... NEW YORK, June 10 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary percutaneous Hepatic Perfusion (PHP(TM)) System for the treatment of cancers of the liver, today announced that it has entered into a definitive agreement to sell ...Regado Biosciences Establishes Medical Advisory Board
...B007). RB007 can be used to completely or partially reverse the anticoagulant effect of RB006. Regado recently completed a phase 2a study of REG1 in percutaneous coronary intervention (PCI) and is planning the initiation of a rigorous phase 2b program in this same indication in 3Q2009. More information can...Delcath Systems Granted Third Orphan Drug Designation
...81118/NY46990LOGO ) Delcath is enrolling patients in a Phase II clinical trial testing its proprietary drug delivery system, known as the Delcath percutaneous Hepatic Perfusion ("PHP") System(TM), with ultra-high doses of the drug melphalan for the treatment of neuroendocrine tumors metastatic to the liver. ...FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
...e to offer this option to my patients." Data from numerous clinical studies have shown that an estimated 10 percent of patients undergoing percutaneous coronary interventions have small vessels (<2.5 mm). Until recently, many physicians were inclined to implant bare-metal stents in these patients ...